Vaxcyte Inc
(NAS:PCVX)
$
102.7
-1.37 (-1.32%)
Market Cap: 12.80 Bil
Enterprise Value: 10.82 Bil
PE Ratio: 0
PB Ratio: 3.79
GF Score: 40/100 
Vaxcyte Inc at Bank of America Global Healthcare Conference Transcript
May 10, 2023 / 09:20PM GMT
Release Date Price:
$52.33
(-1.84%)
Jason Matthew Gerberry
BofA Securities, Research Division - MD in US Equity Research
Thank you so much for joining us at the Bank of America Annual Healthcare Conference. My name is Jason Gerberry, I'm one of the biotech analysts here. I'm pleased to be introducing our next company presenter, Vaxcyte. We've got Grant Pickering, CEO; Andrew Guggenhime, CFO; Jim Wassil, COO. So gentlemen, thanks for joining us.
Grant E. Pickering
Vaxcyte, Inc. - Co-Founder, CEO & Director
Our pleasure. Thank you for having us.
Jason Matthew Gerberry
BofA Securities, Research Division - MD in US Equity Research
So maybe I don't know if you have any brief kind of prepared remarks that you may want to offer up at all, or you just want to jump straight into Q&A.
Grant E. Pickering
Vaxcyte, Inc. - Co-Founder, CEO & Director
I'd say we just jump right into Q&A. We'll let you drive.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers